Your browser doesn't support javascript.
loading
Cervical lymph node metastasis prediction from papillary thyroid carcinoma US videos: a prospective multicenter study.
Zhang, Ming-Bo; Meng, Zhe-Ling; Mao, Yi; Jiang, Xue; Xu, Ning; Xu, Qing-Hua; Tian, Jie; Luo, Yu-Kun; Wang, Kun.
Afiliación
  • Zhang MB; Department of Ultrasound, the First Medical Center, General Hospital of Chinese PLA, Beijing, China.
  • Meng ZL; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
  • Mao Y; Department of Ultrasound, the First Medical Center, General Hospital of Chinese PLA, Beijing, China.
  • Jiang X; Department of Ultrasound, the Fourth Medical Center, General Hospital of Chinese PLA, Beijing, China.
  • Xu N; Department of Ultrasound, Beijing Tong Ren Hospital, Beijing, China.
  • Xu QH; Department of Ultrasound, China-Japan Friendship Hospital, Beijing, China.
  • Tian J; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
  • Luo YK; Department of Ultrasound, the First Medical Center, General Hospital of Chinese PLA, Beijing, China. lyk301@163.com.
  • Wang K; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China. kun.wang@ia.ac.cn.
BMC Med ; 22(1): 153, 2024 Apr 12.
Article en En | MEDLINE | ID: mdl-38609953
ABSTRACT

BACKGROUND:

Prediction of lymph node metastasis (LNM) is critical for individualized management of papillary thyroid carcinoma (PTC) patients to avoid unnecessary overtreatment as well as undesired under-treatment. Artificial intelligence (AI) trained by thyroid ultrasound (US) may improve prediction performance.

METHODS:

From September 2017 to December 2018, patients with suspicious PTC from the first medical center of the Chinese PLA general hospital were retrospectively enrolled to pre-train the multi-scale, multi-frame, and dual-direction deep learning (MMD-DL) model. From January 2019 to July 2021, PTC patients from four different centers were prospectively enrolled to fine-tune and independently validate MMD-DL. Its diagnostic performance and auxiliary effect on radiologists were analyzed in terms of receiver operating characteristic (ROC) curves, areas under the ROC curve (AUC), accuracy, sensitivity, and specificity.

RESULTS:

In total, 488 PTC patients were enrolled in the pre-training cohort, and 218 PTC patients were included for model fine-tuning (n = 109), internal test (n = 39), and external validation (n = 70). Diagnostic performances of MMD-DL achieved AUCs of 0.85 (95% CI 0.73, 0.97) and 0.81 (95% CI 0.73, 0.89) in the test and validation cohorts, respectively, and US radiologists significantly improved their average diagnostic accuracy (57% vs. 60%, P = 0.001) and sensitivity (62% vs. 65%, P < 0.001) by using the AI model for assistance.

CONCLUSIONS:

The AI model using US videos can provide accurate and reproducible prediction of cervical lymph node metastasis in papillary thyroid carcinoma patients preoperatively, and it can be used as an effective assisting tool to improve diagnostic performance of US radiologists. TRIAL REGISTRATION We registered on the Chinese Clinical Trial Registry website with the number ChiCTR1900025592.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Inteligencia Artificial Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Inteligencia Artificial Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article